BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38377777)

  • 1. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
    Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
    Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Cooke EW; Pappas L; Gaffney DK
    Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic performance of the 2023 FIGO staging schema for endometrial cancer.
    Matsuo K; Chen L; Klar M; Lee MW; Machida H; Mikami M; Muderspach LI; Carlson JW; Roman LD; Wright JD
    Gynecol Oncol; 2024 May; 187():37-45. PubMed ID: 38713997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
    Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy.
    Cahan B; Kim JH; Schultheiss TE; Wong JYC; Chen YJ
    Am J Clin Oncol; 2018 Mar; 41(3):302-306. PubMed ID: 26886945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
    Page BR; Pappas L; Cooke EW; Gaffney DK
    Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?
    Abu-Rustum NR; Zhou Q; Iasonos A; Alektiar KM; Leitao MM; Chi DS; Sonoda Y; Soslow R; Hensley M; Barakat RR
    Int J Gynecol Cancer; 2011 Apr; 21(3):511-6. PubMed ID: 21436699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FIGO staging of endometrial cancer: 2023.
    Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
    Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
    Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers.
    Tan PS; Koh E; Pang C; Ong WS; Ngo L; Soh LT; Quek R; Chay WY; Ho TH; Tay SK; Chew SH; Lim-Tan SK; Khoo-Tan H; Lim SL; Busmanis I; Goh LK; Chia YN; Chia WK; Lim T
    Oncologist; 2012; 17(10):1286-93. PubMed ID: 22829569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of Controversies and Unresolved Issues in the 2014 FIGO Staging System for Endometrial Cancer: Survey Results From Members of the International Society of Gynecological Pathologists and International Gynecologic Cancer Society.
    Kayraklioglu N; Katsakhyan L; Cohen PA; Singh N; Rabban JT; Matias-Guiu X
    Int J Gynecol Pathol; 2024 May; 43(3):242-252. PubMed ID: 37668357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
    Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
    Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
    Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
    Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
    Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
    Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the extent of lymphadenectomy a prognostic factor in International Federation of Gynecology and Obstetrics stage II endometrioid endometrial cancer?
    Cuylan ZF; Akilli H; Gungorduk K; Demirkiran F; Oz M; Salman MC; Sozen H; Celik H; Gokcu M; Bese T; Meydanli MM; Ozgul N; Topuz S; Kuscu E; Kuru O; Gokmen S; Gultekin M; Ayhan A
    J Obstet Gynaecol Res; 2021 Mar; 47(3):1134-1144. PubMed ID: 33426779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.